Oncology & Cancer

Molecular mechanisms behind AICAr drug; impact on ALL

AICAr (5-amino-4-imidazolecarboxamide riboside, also called Acadesine) has been found to inhibit cell proliferation and has cytotoxic potential for childhood acute lymphoblastic leukemia (ALL) cells. Much of the drug's cytotoxic ...

Oncology & Cancer

Drug hobbles deadly liver cancer by stifling protein production

In laboratory experiments, UC San Francisco researchers successfully beat back the growth of aggressive liver cancers using a surprising new approach. Traditionally, targeted cancer therapies aim to disable proteins borne ...

Genetics

New biomarker links cancer progression to genome instability

Our DNA is under constant attack. The delicate molecule that contains our genetic information is extremely vulnerable to everything from environmental agents, such as radiation, to the chemicals in the air we breathe and ...

Oncology & Cancer

How skin cancer cells sidestep the immune system

Researchers at the Mainz University Medical Center have discovered a new signal pathway employed by skin cancer cells to avoid attack by the immune system. In an animal model and through analysis of human tissue samples, ...

Oncology & Cancer

Protein analysis uncovers new cancer subtypes for medulloblastoma

Two patients with the same kind of tumor can have very different experiences. One patient's cancer may progress quickly while the other grows slowly. Treatments may shrink tumors or have no effect at all. And some patients ...

page 23 from 40